Point72 Asset Management’s T2 Biosystems, Inc TTOO Stock Holding History

Point72 Asset Management’s Portfolio TTOO Stock Details TTOO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-120	Closed	-$1.01M	–	1538
2019 Q2	$1.01M	Hold	120	–	–	0.01%	771
2019 Q1	$1.58M	Buy	120 +56	+88%	+$953K	0.01%	740
2018 Q4	$956K	Sell	64 -4	-6%	-$94K	﹤0.01%	812
2018 Q3	$2.51M	Hold	68	–	–	0.01%	727
2018 Q2	$2.61M	Buy	68 +38	+127%	+$1.44M	0.01%	725
2018 Q1	$964K	Hold	30	–	–	﹤0.01%	817
2017 Q4	$618K	Hold	30	–	–	﹤0.01%	837
2017 Q3	$630K	Buy	+30	New	+$557K	﹤0.01%	785
2017 Q1	–	Sell	-73	Closed	-$1.93M	–	1002
2016 Q4	$1.93M	Sell	73 -77	-51%	-$2.37M	0.01%	568
2016 Q3	$5.43M	Sell	150 -54	-26%	-$1.77M	0.04%	404
2016 Q2	$8.03M	Sell	204 -16	-7%	-$722K	0.05%	338
2016 Q1	$10.8M	Hold	220	–	–	0.08%	269
2015 Q4	$12M	Buy	220 +120	+120%	+$6.47M	0.1%	240
2015 Q3	$4.38M	Buy	100 +65	+186%	+$4.32M	0.03%	443
2015 Q2	$2.85M	Buy	+35	New	+$3.04M	0.02%	537

Other funds holding TTOO

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Gagnon Securities New York $433M AUM 29.08% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

EIM

Essex Investment Management Boston, Massachusetts $632M AUM 95.36% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

GIM

Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

Point72 Asset Management's TTOO Position: Q3 2019 in Review

Point72 Asset Management sold out of T2 Biosystems, Inc (TTOO) in Q3 2019, closing a stake of 120 shares — an estimated $1.01M sold.

Point72 Asset Management first reported a position in TTOO in Q2 2015 and held it in 15 quarters. The position peaked at $12M in Q4 2015. 48 funds tracked by Wall St. Rank hold TTOO as of Q3 2019.

Point72 Asset Management reported no remaining T2 Biosystems, Inc position as of Q3 2019 after selling out during the quarter.
Point72 Asset Management sold 120 T2 Biosystems, Inc shares in Q3 2019, an estimated $1.01M.
Point72 Asset Management first reported a position in T2 Biosystems, Inc in Q2 2015 and held it in 15 quarters.
Point72 Asset Management's T2 Biosystems, Inc position peaked at $12M in Q4 2015.
48 funds tracked by Wall St. Rank held T2 Biosystems, Inc as of Q3 2019.

Based on Point72 Asset Management's 13F filing for Q3 2019, filed 15 Nov 2019.